Submission Instructions

American Diabetes Association

70th Scientific Sessions

June 25-29, 2010

Orlando, FL

Abstract Submission Deadline - Extended to:

Monday, January 11, 2010 at 11:00 AM EST

Step-by-Step Instructions for Submitting an Abstract

We recommend that you print this page and use it as a reference during the submission process.

1. Update your account information by clicking the My Profile link under the site banner in the upper right corner.
   
   
2. Click the steps on the left navigation menu and complete each section by following the instructions provided.
   
   
3. Save your work by clicking on the "Save" or “Next” button located within each section. Once your work is saved, you may leave the submission site and return later to complete your abstract.
   
   
4. Category and Presentation Preference:
   
   
   • Category: Indicate the appropriate category in which you wish to have the abstract reviewed. Please consult the abstract category listings. NOTE: The Scientific Sessions Planning Committee reserves the right to move an abstract to a different abstract category.
     
     
   • Presentation Preference: The Scientific Sessions Meeting Planning Committee will consider presentation preference when planning the program. The author's wishes will be followed, if possible, but are not guaranteed. An abstract marked as "Only" indicates the authors do not want an abstract considered for any other type of presentation. However, if an abstract is marked as "Oral Only" and is not selected for an oral presentation, the Committee may determine, for programming reasons, that it should be placed in a poster session. Choosing "Oral Only" will not guarantee its selection for the program. Choosing "No Preference" allows for greater flexibility in its placement. The Committee reserves the right of final decision.
     
5. Financial Support:
   
   
   • ADA Support: If the research presented in this abstract has been supported, in whole or in part, by a grant from the American Diabetes Association, please select yes. Accepted abstracts noted with ADA funding will be highlighted in the 70th Scientific Sessions Abstract Book, the June 2010 supplement to the journal Diabetes. The response to this question will not affect the acceptance of the abstract.
     
     
   • Other Grant Support: If a grant provider requires acknowledgment of financial support with the printed abstract, enter the grant information in the provided text box (200 maximum characters). The response to this question will not affect the acceptance of the abstract. Text entered in the Grant Support text box will not count towards the 2,300 character count limit.
6. Keyword(s): Enter up to 3 keywords as appropriate for your abstract. A minimum of one keyword is required.
   
   
7. Author Information:
   
   
   • Author Sequence: Specify the order of author names by typing the position number into the “Author Sequence” box. To rearrange the order of the authors, click the “pencil icon” next to the author's name and then edit the number in the "Author Sequence" box.
   • Author: Include complete first and last name(s) in mixed case (e.g., Jane E. Doe). Authors who appear on more than one abstract should list their names the same way on all abstracts.
   • Presenting Author: Designate the Presenting Author for the abstract by checking the “Presenting Author” box. You may only designate one Presenting Author for the abstract.
   • Corresponding Author: Designate the Corresponding Author for the abstract by checking the "Corresponding Author" box. You may only designate one Presenting Author for the abstract.
   • Institution: Enter the Institution name, city, and country. The Institution state is required for locations in the United States and Canada.
   • Contact Information: Author email address and preferred contact phone number are required only for the Presenting and Corresponding Author(s).
8. Author Disclosure: Every author on each abstract must complete the Author Disclosure section. This form is required for all authors on each abstract submitted. All disclosure information must be entered on the disclosure page and saved. If an abstract author has a financial interest or other relationship with the manufacturer(s) of any diabetes management product(s) or provider(s) of any diabetes management services, please indicate that relationship by using the drop down menus. Each author on the abstract must complete a separate Disclosure Form for each abstract. Once you save your disclosure, the Preview Abstract page on the website will display your disclosures. This page can be printed for your records.
   
   
9. Sponsor: A current professional member of the ADA is required to sponsor (validate) the abstract. The sponsor does not need to be an author. There is no limit to the number of abstracts an ADA member may sponsor.
   
   
10. Abstract Title: The first letter of major words in the abstract title should be capitalized (e.g., "Regulation of Insulin Signaling Pathways"). Use capital and lower case letters, as appropriate, for abbreviations in the title (i.e. mRNA).
    
    
11. Abstract Body: Make abstracts as informative as possible, including a brief statement of the purpose of the study or why it was done, the methods used, the results observed, and the author(s)' conclusions based upon the results. Actual data should be summarized. It is inadequate to state "The results will be discussed" or "The data will be presented." See Specific Abstract Requirements on the Abstract Guidelines page for abstract requirements.
    
    
12. Create or Edit Table: Simple tables may be included if they fit within the size constraints of the electronic program. Use the table formatting function for table preparation. Tables created using the submission system can have a maximum of 8 columns. There is no limit on the number of characters in a table. However, the characters in the table count towards the 2,300 character count limit. An abstract can have up to 2 attachments (tables and/or figures).
    
    
13. Add or Revise Figure: Figures or graphics may be uploaded if they fit within the size constraints of the electronic program. Follow the instructions in the program for submitting image files. Each figure counts as 320 characters. An abstract can have up to 2 attachments (tables and/or figures).
    
    
14. Character Count: The size limit for the abstract (including title, body, tables and figures) is 2,300 characters. The character count does include spaces. NOTE: There is no limit on the number of characters in a table. However, the character count of the table counts towards the 2,300 character count limit. Each figure counts as 320 characters. An abstract can have up to 2 tables and/or figures.
    
    
15. Preview Abstract: This is a preview copy only, allowing you to view your abstract as it currently appears in the program. You may go back to any section to make changes or edit your abstract. NOTE: You may not submit your abstract from this preview screen.
    
    
16. Submit Abstract: After you have checked your abstract for accuracy, click the “Submit Final Document” button at the top of the screen. This final step must be taken in order for your abstract to be transmitted properly. Please be sure to verify that your abstract is correct at the time of submission. Submitted abstracts may be edited online up until the submission deadline: Friday, January 8, 2010 at 5:00 PM. No further editing is permitted after the deadline.
    
    
17. Payment: A non-refundable processing fee of $65.00 (USD) must be paid for each abstract submitted to the ADA. Payment must be made by credit card. Major credit cards (American Express, VISA, and MasterCard) are accepted for the secure online payment.
    
    
18. Copyright Transfer Agreement: Abstracts accepted for "Presentation" and "Published Only" are published in the June 2010 supplement to the journal Diabetes. The publication of these abstracts must follow copyright assignment requirements for the journal. As such, the Corresponding Author is responsible for obtaining signatures from all abstract authors on one form in order for the abstract to be published. All submitted abstracts must have a completed Copyright Transfer Agreement onfile. If the abstract is not selected for publication, the copyright will revert back to the authors. Submission of the  Copyright Transfer Agreement does not imply abstract acceptance. For further information or questions, please contact abstracts@diabetes.org.
    
    IMPORTANT: Once your abstract has been submitted, please make sure to fax the completed Copyright Transfer Agreement Form to the ADA at 703-991-0621 by Monday, February 1, 2010, in order to qualify for publication in the journal Diabetes.

Important Submission Tips

This section contains useful tips to guide you through the online Abstract Submission process.

• Click the buttons on the left navigation menu and complete each section. Be careful to follow the instructions.
  
  
• Save your work by clicking the "Save" or "Next" buttons. Be sure to save your work before logging off the site.This does not submit your abstract for review.
  
  
• You can log off at any time without submitting your abstract and return to continue your work at another time. An abstract can be edited and revised online as many times as needed, up until the submission deadline. If you give your username and password to another person, they will have access to edit all abstracts you have submitted.
  
  
• Print out and check the abstract preview to verify that it is correct before completing the submission process.
  
  
• Click the Submit Abstract menu item and submit your abstract ONLY when you are sure that your abstract is complete and in final form.
  
  
• Submitted abstracts may be edited online up until the Submission Deadline: Friday, January 8, 2010 at 5:00 PM EST. After the final deadline, additional editing is not permitted.
  
  
• Payment of the $65.00 (USD) fee must be made in order to complete submission of your abstract.
  
  

Extended Deadline: All abstracts must be submitted by
Monday, January 11, 2010 at 11:00 AM EST

If your abstract is not complete by this date, your abstract will not be considered for Scientific Sessions.